EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Stent Thrombosis: A Narrative Review From Pathophysiology to Therapy

Emanuele Cecchi, Andrea Grasso Granchietti, Ruggero Mazzotta iD, Manuel Garofalo iD, Giorgia Panichella, Giuseppe Iula, Francesca Maria Di Muro iD, Silvia Menale, Rossella Marcucci

Clinical Cardiology · 2026-04 · 49 (4)

DOI: 10.1002/clc.70286 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Cardiology, online erschienen am 30.03.2026. Verfasst von Emanuele Cecchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Florence, School of Human and Health Science, Florence, Italy. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Coronary Thrombosis, Stents, Drug-Eluting Stents. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Stent thrombosis (ST) remains a rare but potentially life‐threatening complication of percutaneous coronary intervention (PCI), associated with high rates of myocardial infarction and mortality. Despite advances in stent technology and antithrombotic therapy, its multifactorial pathophysiology and optimal management remain challenging.

Methods

We performed a narrative review of the current literature focusing on the pathophysiological mechanisms, clinical predictors, and contemporary management strategies of ST. Particular attention was given to stent‐related, pharmacological, and patient‐related factors, as well as emerging therapeutic approaches and preventive strategies.

Results

ST arises from the complex interplay between mechanical factors (e.g., stent malapposition, underexpansion, and neoatherosclerosis), pharmacological aspects (e.g., premature discontinuation or inadequate response to dual antiplatelet therapy), and patient‐related conditions, including hypercoagulability and systemic inflammation. In the acute setting, prompt PCI with restoration of coronary flow remains the cornerstone of treatment, while intravascular imaging plays a key role in identifying underlying mechanisms and optimizing outcomes. Preventive strategies rely on procedural optimization, appropriate antithrombotic therapy, and careful patient selection. New‐generation drug‐eluting stents and imaging‐guided PCI have reduced ST incidence, whereas emerging approaches—including drug‐coated balloons, subcutaneous antiplatelet agents, and anti‐inflammatory therapies—represent promising adjunctive strategies, although ST‐specific benefits are not yet fully established.

Conclusions

ST is a multifactorial complication requiring an integrated approach combining optimized PCI techniques, tailored antithrombotic therapy, and careful risk stratification. Ongoing advances in device technology and pharmacological treatments, along with a growing understanding of inflammatory pathways, may further improve prevention and clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionCoronary ThrombosisStentsDrug-Eluting StentsPlatelet Aggregation InhibitorsFibrinolytic AgentsCoronary Artery DiseaseHumansRisk FactorsProsthesis DesignTreatment Outcome

Stichwörter der Autor:innen

acute coronary syndromedrug‐eluting stentdual‐antiplatelet therapyhypercoagulabilityneoatherosclerosisstent thrombosis

Substanzen

Platelet Aggregation InhibitorsFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Florence, School of Human and Health Science, Florence, Italy.
  • General Cardiology Unit, Department of Cardiac Thoracic and Vascular Medicine, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
  • The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Cardiovascular Department, San Donato Hospital, Arezzo, Italy.
  • Center for Atherothrombotic Disease, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

ORCID-Profile: Ruggero Mazzotta, Manuel Garofalo, Francesca Maria Di Muro

Zitieren

APA

Cecchi, E., Granchietti, A. G., Mazzotta, R., Garofalo, M., Panichella, G., Iula, G., Di Muro, F. M., Menale, S., & Marcucci, R. (2026). Stent Thrombosis: A Narrative Review From Pathophysiology to Therapy. Clinical Cardiology, 49(4). https://doi.org/10.1002/clc.70286

Vancouver

Cecchi E, Granchietti AG, Mazzotta R, Garofalo M, Panichella G, Iula G, et al. Stent Thrombosis: A Narrative Review From Pathophysiology to Therapy. Clinical Cardiology. 2026;49(4). doi:10.1002/clc.70286

BibTeX
@article{Cecchi2026,
  author = {Cecchi, Emanuele and Granchietti, Andrea Grasso and Mazzotta, Ruggero and Garofalo, Manuel and Panichella, Giorgia and Iula, Giuseppe and Di Muro, Francesca Maria and Menale, Silvia and Marcucci, Rossella},
  title = {Stent Thrombosis: A Narrative Review From Pathophysiology to Therapy},
  journal = {Clinical Cardiology},
  year = {2026},
  volume = {49},
  number = {4},
  doi = {10.1002/clc.70286}
}
Kostenlos starten →